FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer.
Kochi
Mitsugu
M
Department of Digestive Surgery, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan. gann@med.nihon-u.ac.jp
Fujii
Masashi
M
Kaiga
Teruo
T
Takahashi
Toru
T
Morishita
Yukie
Y
Kobayashi
Michiyo
M
Kasakura
Yuichi
Y
Takayama
Tadatoshi
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D002945:Cisplatin / Q000008:administration & dosage; D018572:Disease-Free Survival; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D016019:Survival Analysis; D016896:Treatment Outcome; D000509:alpha-Fetoproteins / Q000378:metabolism*
D014408:Biomarkers, Tumor; D000509:alpha-Fetoproteins; D005047:Etoposide; D002945:Cisplatin; D002955:Leucovorin; D005472:Fluorouracil